Safety and Efficacy of Goal-directed Cardiovascular Regulation Techique Based on Systemic Blood Pressure and Blood Volume Resitiction during Major Hepatic Resection

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-INR-16008101

Enrollment

Unknown

Registered

2016-03-15

Start date

2016-03-01

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Hepatic Tumor

Interventions

Control group:Goal-directed Cardiovascular Regulation Techique Based on Systemic Blood Pressure and Blood Volume Restriction

the new treatment group:Goal-directed Cardiovascular Regulation Techique Based on Systemic Blood Pressure and Blood Volume Resitiction

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who are diagnosed of having an major hepatic tumor aged between 18-70 years.

Exclusion criteria

Exclusion criteria: Those who are diagnosed coagulation disorder, severe liver dysfunction, severe coronary artery artery stenosis, cerebravascular obstructive disease, congnitive dysfunction.

Design outcomes

Primary

Measure	Time frame
Blood Loss;rate of inferior vena cava occlusion;hepatic portal occlusion time;	—

Countries

China

Contacts

Public ContactWang Ying

The Fourth Affiliated Hospital of Harbin Medical University

wangying1971yibo@163.com+86 13936240373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026